tegafur has been researched along with Pseudomyxoma Peritonei in 1 studies
Pseudomyxoma Peritonei: A peritoneal adenocarcinoma characterized by build-up of MUCUS in the PERITONEAL CAVITY. Mucus secreting cells may attach to the peritoneal lining and continue to secrete mucus. The majority of cases represent tumor spread from a primary low-grade mucinous neoplasm of the APPENDIX (NCI Thesaurus).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 74-year-old male with diffuse gelatinous ascites underwent cytoreductive surgery including ileocecal resection and greater omentectomy." | 5.35 | [A case report of pseudomyxoma peritonei demonstrating complete response after intensive therapy consisting of cytoreductive surgery and adjuvant chemotherapy with paclitaxel and S-1]. ( Fujitani, K; Hirao, M; Ikenaga, M; Kashiwazaki, M; Manoh, M; Mishima, H; Miyazaki, M; Nakamori, S; Ogawa, H; Takeda, M; Tsujinaka, T; Yasui, M, 2008) |
| "A 74-year-old male with diffuse gelatinous ascites underwent cytoreductive surgery including ileocecal resection and greater omentectomy." | 1.35 | [A case report of pseudomyxoma peritonei demonstrating complete response after intensive therapy consisting of cytoreductive surgery and adjuvant chemotherapy with paclitaxel and S-1]. ( Fujitani, K; Hirao, M; Ikenaga, M; Kashiwazaki, M; Manoh, M; Mishima, H; Miyazaki, M; Nakamori, S; Ogawa, H; Takeda, M; Tsujinaka, T; Yasui, M, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujitani, K | 1 |
| Ogawa, H | 1 |
| Takeda, M | 1 |
| Hirao, M | 1 |
| Yasui, M | 1 |
| Kashiwazaki, M | 1 |
| Ikenaga, M | 1 |
| Miyazaki, M | 1 |
| Mishima, H | 1 |
| Nakamori, S | 1 |
| Manoh, M | 1 |
| Tsujinaka, T | 1 |
1 other study available for tegafur and Pseudomyxoma Peritonei
| Article | Year |
|---|---|
[A case report of pseudomyxoma peritonei demonstrating complete response after intensive therapy consisting of cytoreductive surgery and adjuvant chemotherapy with paclitaxel and S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Hum | 2008 |